RXR agonists (AIBIOS)

N/A

Report date: 2025/01/26 17:04:20
NME

Base Information

Drug NameRXR agonists (AIBIOS)
Drug Alias NameCU-6-PMN
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionRetinoid X receptor alpha agonists
TargetsRetinoid X receptor alpha
Therapy Area/IndicationsDiabetes Mellitus, Type 2Alzheimer DiseaseParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryJapan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAIBIOS Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAIBIOS Co Ltd
Inactive CompaniesN/A
Active IndicationsDiabetes Mellitus, Type 2Alzheimer DiseaseParkinson Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A